Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Response dependent treatment of stages IA, IIA and IIIA Hodgkin's disease with DBVE (doxorubicin/bleomycin/vincristine/etoposide) and low dose involved field irradiation with or without Zinecard: a pediatric oncology group phase III study.

Next Previous
X
Search
Trial Profile

Response dependent treatment of stages IA, IIA and IIIA Hodgkin's disease with DBVE (doxorubicin/bleomycin/vincristine/etoposide) and low dose involved field irradiation with or without Zinecard: a pediatric oncology group phase III study.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexrazoxane (Primary) ; Bleomycin; Doxorubicin; Etoposide; Filgrastim; Vincristine
  • Indications Hodgkin's disease
  • Focus Therapeutic Use

    • Most Recent Events

    • 13 Oct 2021 Results of pooled analysis (n=1308) assessing long-term outcomes among children newly diagnosed with cancer who were treated in dexrazoxane-containing clinical trials (P9404, P9425, P9426, DFCI 95-01 and P9754), published in the Cancer.
    • 31 May 2020 Results (N=173), subgroup analysis of data pooled from 5 randomized trials (P9404, P9425, P9426, DFCI 95-01 and P9754) assessing cardiac function in long-term survivors , plus a matched group of osteosarcoma survivors treated with Doxorubicin alone, presented at the 56th Annual Meeting of the American Society of Clinical Oncology
    • 16 Sep 2005 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top